Difference between revisions of "Part:BBa K2804002"
| Line 8: | Line 8: | ||
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here | ||
===Usage and Biology=== | ===Usage and Biology=== | ||
| + | |||
| + | ==Added by KEYSTONE_A 2020== | ||
| + | |||
| + | BMP2 and VEGF inhibition promote expression of cartilaginous pathways on sorted skeletal stem-cell (SSC) in vitro. | ||
| + | |||
| + | [[File:KEYSTONE A BMP2 VEGFR effect.jpg|600px|thumb|left|'''Figure: SSC gene expression levels after in vitro treatment of PBS, BMP2, or sVEGFR1.''']] | ||
| + | |||
| + | '''Reference''' | ||
| + | |||
| + | Murphy, M. P., Koepke, L. S., Lopez, M. T., Tong, X., Ambrosi, T. H., Gulati, G. S., ... & Steininger, H. (2020). Articular cartilage regeneration by activated skeletal stem cells. Nature Medicine, 1-10. | ||
| + | |||
<!-- --> | <!-- --> | ||
Revision as of 13:40, 24 October 2020
Bone morphogenetic protein 2 (BMP2)
The human bone morphogenetic protein 2 is a bone-growth regulatory factor well known to be a potent osteoinductive protein.
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]